Allergy Therapeutics plc (AIM:AGY)
London · Delayed Price · Currency is GBP · Price in GBX 5.70
+0.30 (5.56%)
Jul 28, 2026, 9:00 AM GMT
Allergy Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 10.08 | 12.79 | 12.92 | 14.85 | 20.52 | 40.27 |
Cash & Short-Term Investments | 10.08 | 12.79 | 12.92 | 14.85 | 20.52 | 40.27 |
Cash Growth | -21.16% | -0.97% | -13.00% | -27.64% | -49.06% | 8.96% |
Accounts Receivable | 10.98 | 5.92 | 5.94 | 5.83 | 10.47 | 6.22 |
Other Receivables | 1.4 | 2.06 | 1.89 | 1.26 | - | - |
Total Trade Receivables | 12.38 | 7.97 | 7.82 | 7.09 | 10.47 | 6.22 |
Inventory | 13.79 | 13.92 | 12.74 | 11.59 | 11.41 | 10.84 |
Other Current Assets | - | - | - | - | - | 0.53 |
Total Current Assets | 36.25 | 34.68 | 33.48 | 33.53 | 42.39 | 57.86 |
Net Property, Plant & Equipment | 26.39 | 24.26 | 23.75 | 23.24 | 20.19 | 19.72 |
Other Intangible Assets | 0.86 | 0.93 | 1.37 | 1.79 | 1.69 | 1.41 |
Goodwill | 3.34 | 3.33 | 3.32 | 3.35 | 3.35 | 3.34 |
Other Long-Term Assets | 4.16 | 4.35 | 4.49 | 6.52 | 5.33 | 5.76 |
Total Assets | 71 | 67.54 | 66.41 | 68.43 | 72.95 | 88.09 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 13.95 | 13.62 | 12.76 | 13.56 | 15.67 | 16.48 |
Current Portion of Long-Term Debt | 0.45 | 0.41 | 0.6 | 0.65 | 0.95 | 0.96 |
Current Portion of Leases | 1.51 | 1.48 | 1.52 | 1.16 | 1.32 | 0.79 |
Other Current Liabilities | 16.12 | 11.69 | 3.92 | 3.2 | 0.12 | - |
Total Current Liabilities | 32.03 | 27.19 | 18.8 | 18.57 | 18.05 | 18.23 |
Long-Term Debt | 19.71 | 53.04 | 22.5 | 26.44 | 1.5 | 2.45 |
Long-Term Leases | 5.08 | 5.17 | 6.37 | 7.75 | 6.76 | 6.97 |
Other Long-Term Liabilities | 9.94 | 10.34 | 11.38 | 11.57 | 8.87 | 11.91 |
Total Long-Term Liabilities | 34.73 | 68.54 | 40.25 | 45.75 | 17.13 | 21.32 |
Total Liabilities | 66.76 | 95.74 | 59.05 | 64.32 | 35.18 | 39.55 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 6.14 | 4.77 | 4.78 | 0.69 | 0.65 | 0.65 |
Additional Paid-in Capital | 250.94 | 200.83 | 196.89 | 162.48 | 155.5 | 155.4 |
Accumulated Other Comprehensive Income | 1.51 | 1.44 | 0.96 | 0.77 | 0.15 | -0.12 |
Retained Earnings | -254.34 | -235.23 | -195.28 | -159.83 | -118.54 | -107.4 |
Shareholders' Equity | 4.25 | -28.19 | 7.36 | 4.11 | 37.77 | 48.54 |
Total Liabilities & Equity | 71 | 67.54 | 66.41 | 68.43 | 72.95 | 88.09 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 26.75 | 60.09 | 30.99 | 35.99 | 10.53 | 11.17 |
Net Cash (Debt) | -16.67 | -47.3 | -18.07 | -21.14 | 9.99 | 29.1 |
Net Cash Growth | - | - | - | - | -65.69% | 17.42% |
Net Cash Per Share | -0.00 | -0.01 | -0.01 | -0.03 | 0.02 | 0.04 |
Book Value | 4.25 | -28.19 | 7.36 | 4.11 | 37.77 | 48.54 |
Book Value Per Share | 0.00 | -0.01 | 0.00 | 0.01 | 0.06 | 0.07 |
Tangible Book Value | 0.05 | -32.45 | 2.67 | -1.03 | 32.73 | 43.78 |
Tangible Book Value Per Share | 0.00 | -0.01 | 0.00 | -0.00 | 0.05 | 0.06 |